Participant Experience

Print

Past participants of this course consistently report that this program has inspired and improved their clinical practice and outcomes. Here are a few comments from recent attendees:

 

More than any conference I have attended recently, speakers with vast knowledge from the most advanced medical centers in the country offered examples of unusual and interesting cases which can easily be applied to my community setting.

 

The knowledge I gained on hereditary GI cancers concerning the genetics and clinical disease was better than any I have ever read or heard. The course made a complex subject much clearer to me.

 

This course has led to my updating/improving my approach to diagnosis and management of multiple GI disorders, including esophageal dysmotility, pancreatic masses, HBV and HCV infections, IBS.

 

I am now better able to teach my patients about their disease using evidence-based theories, and am more confident in my approach to complicated workups.

 

The knowledge I gained from this course has changed many components of my care of celiac patients, from discussion with the patient to diagnosis and follow-up practices.

 

My workup for chronic pancreatitis has changed due to this course.

 

The very high quality, experience, and expertise of the faculty made this course exceptional.

 

As a primary care provider, I am now more comfortable discussing more aggressive lifestyle changes with my patients, am able to handle more complicated GI patients, and know when to refer.

 

I have overhauled my approach to the removal of small polyps, my approach to initial hydration in pancreatitis, and my approach to withholding / restarting anticoagulant meds pre- and post-procedure.

 

My practice has changed in many ways since attending this program: I am better at checking vitamins and looking for deficiencies in post-gastric bypass patients; I am more confident in treating IBD patients and choosing among the different biologics; have been using more antidepressant meds with IBS patients and doing a better job selling this therapy to them; and I now start to do EGD earlier on anticoagulated UGI bleeding instead of waiting for their INR to decrease.

 

The speakers were superb.  The content was balanced, appropriate for the general practice of gastroenterology.

 

I now have better endoscopic management in the setting of anticoagulants, improved management of GI bleeding, both upper and lower, and improved screening for genetic disorders in GI cancer.

 

I have begun to implement an acute pancreatitis protocol in my hospital--I found the comparison to acute MI very relevant.

 

I was super impressed with all the faculty! So smart, prepared and interesting.

 

I have updated my treatment of C. difficile colitis, and the evaluation and treatment of NAFLD.

 

This course has changed the way I manage IBS and celiac disease, and my approach to chronic pancreatitis assessment.

 

My approach to CRC screening has improved—I am able to better guide patients on how to compare and contrast the different modalities available.

 

For patients with C. Diff, my practice has become more conscientious of VRE.

 

This course gave me many more complaint-based treatment options for functional patients. I am now also more likely to utilize MRI for evaluation of liver lesions and to try tricyclics with refractory GERD patients.

 

This course is leading to many updates in my own practice: Use of fecal calprotectin, use of small cold snares for small polyps instead of jumbo forceps, impact of epidemiology of pancreatic cancer, new appreciation of the disease and the gut microbiome.

 

I have made changes in my treatment of hepatitis patients with the new information from this course on end-stage liver disease. I also have made changes in the diagnosing and treatment of esophageal motility disorders.

 

I have been motivated by this course to work to establish fecal transplantation at my institution. 

 

I now use backdown for visceral hypersensitivity, and recommend liver bx for patients with possible small duct disease.

 

I have this course to thank for improvements in my management C diff.; my care of obese patients; and my increased use of gabapentin for abdominal pain management.

 

I have updated my approach to functional GI disorders—especially non-cardiac chest pain, burning esophagus—and have implemented genetic screening in relation to colonic polyp disease.

 

What I found truly exceptional was the quality of your younger faculty members—their depth of knowledge and their ability to deliver their message in an interesting way.

 

This course has given me extremely useful tips to diagnose and manage micronutrient deficiencies.

 

Large amounts of clinically relevant recommendations from this course concerning the difficult polyp, anticoagulation and GI procedures, and pancreatic cysts have improved my practice.

 

This was a great conference! I learned a great deal about IBD, about when to start/stop biologic, if possible; and new drugs on the horizon for IBD treatment. My approach to the management of patients on anticoagulation and needing a GI procedure has improved, as have my techniques to remove difficult polyps.